Medicare options to be topic (The Ithaca Journal)
Action for Older Persons, Inc. is presenting a free seminar on Understanding Your Medicare Options at 12:30 p.m. June 25 at the Johnson City Senior Center, 30 Brocton St.

Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with ... (News-Medical-Net)
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive.